Linden, H. M., Kurland, B. F., Peterson, L. M., Schubert, E. K., Gralow, J. R., Specht, J. M., . . . Mankoff, D. A. (2011). Fluoroestradiol (FES) Positron Emission Tomography (PET) Reveals Differences In Pharmacodynamics Of Aromatase Inhibitors, Tamoxifen, And Fulvestrant In Patients With Metastatic Breast Cancer.
Chicago-стиль цитированияLinden, Hannah M., et al. Fluoroestradiol (FES) Positron Emission Tomography (PET) Reveals Differences In Pharmacodynamics Of Aromatase Inhibitors, Tamoxifen, And Fulvestrant In Patients With Metastatic Breast Cancer. 2011.
MLA-цитированиеLinden, Hannah M., et al. Fluoroestradiol (FES) Positron Emission Tomography (PET) Reveals Differences In Pharmacodynamics Of Aromatase Inhibitors, Tamoxifen, And Fulvestrant In Patients With Metastatic Breast Cancer. 2011.